[1] Hsu YC, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol, 2023,20(8):524-537. [2] Alberts CJ, Clifford GM, Georges D, et al. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. Lancet Gastroenterol Hepatol, 2022,7(8):724-735. [3] 胡秀娟,张丽,王燕,等. 扶脾利水消鼓方结合中医辨证施膳对乙型病毒性肝炎LC腹水肝功能、营养指数的影响. 中华中医药学刊,2024,42(7):193-196. [4] Chen YL, Zhao ZW, Li SM, et al. Value of red blood cell distribution width in prediction of diastolic dysfunction in cirrhotic cardiomyopathy. World J Gastroenterol, 2023,29(15):2322-2335. [5] Dourakis SP, Geladari E, Geladari C, et al. Cirrhoticcardiomyopathy: The interplay between liver and cardiac muscle. How does the cardiovascular system react when the liver is diseased? Curr Cardiol Rev, 2021,17(1):78-84. [6] Kaur H, Premkumar M. Diagnosis andmanagement of cirrhotic cardiomyopathy. J Clin Exp Hepatol, 2022,12(1):186-199. [7] 刘婷婷,丁明岩,孙丹丹,等. TDI联合2D-STI评价ANOCA患者微循环功能障碍及左心功能损伤的应用价值. 中华心血管病杂志,2021,49(12):1191-1197. [8] Palamuthusingam D, Reyaldeen R, Johnson DW, et al. Assessment of cardiac structure and function in kidney failure: understanding echocardiography and magnetic resonance imaging for the nephrologist. Int Urol Nephrol, 2021,53(4):699-712. [9] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2022年版).实用肝脏病杂志,2023,26(3)S18-39. [10] 中华医学会肝病学分会. 肝硬化诊治指南.实用肝脏病杂志,2019,22(6):770-792. [11] Kok B, Abraldes JG. Child-Pughclassification: Time to abandon? Semin Liver Dis, 2019,39(1):96-103. [12] European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol, 2018,69(2):406-460. [13] Kostyusheva A, Brezgin S, Glebe D, et al. Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modification. Emerg Microbes Infect, 2021,10(1):2264-2275. [14] Almeida F, Sousa A. Cirrhotic cardiomyopathy: Pathogenesis, clinical features, diagnosis, treatment and prognosis. Rev Port Cardiol, 2024,43(4):203-212. [15] Rimbaş RC, Rimbas M, Chitroceanu AM, et al. Cirrhoticcardiomyopathy in the era of liver transplantation: Time for precise stepwise evaluation. J Gastrointestin Liver Dis, 2020,29(4):665-675. [16] Karabacak M, Peynirci A, Ozdil O, et al. Therelationship between global left ventricular function, as indicated by the Tei index, and long-term survival in patients with non-ischemic, dilated cardiomyopathy. Kardiologiia, 2023,63(10):78-83. [17] Özde Ş, Kayapınar O, Doğru M, et al. Evaluation of theearly effects of childhood asthma and its treatment on cardiac function as revealed by two-dimensional speckle-tracking echocardiography. Pediatr Cardiol, 2024,45(4):858-866. [18] Schneider M, Bartko P, Geller W, et al. A machine learning algorithm supports ultrasound-naïve novices in the acquisition of diagnostic echocardiography loops and provides accurate estimation of LVEF. Int J Cardiovasc Imaging, 2021,37(2):577-586. [19] Depla AL, De Wit L, Steenhuis TJ, et al. Effect of maternal diabetes on fetal heart function on echocardiography: systematic review and meta-analysis. Ultrasound Obstet Gynecol, 2021,57(4):539-550. [20] 朱春芬,任春霖,郭霞. 肝硬化性心肌病患者临床特点、心电图表现和危险因素分析. 实用肝脏病杂志,2024,27(3):414-417. [21] Xu H, Zhang Y, Gao Y. Prevalence and risk factors for cirrhotic cardiomyopathy: a prospective cross-sectional study. Eur J Gastroenterol Hepatol,2024,36(4):469-475. |